Association between Lung Function and Vocal Affections Arising from Tobacco Consumption

Santos, Karoline Weber dos; Echeveste, Simone Soares; Vidor, Deisi Cristina Gollo Marques

doi:10.1055/s-0033-1358586

Cited by 3 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Tobacco consumption reduces the lung vital capacity and other parameters of voice. The time and amount of consumption had a direct relationship with the vocal and maximum phonation time [16] . All voice-related disorders can be corrected with proper vocal hygiene training.…”

Section: Resultsmentioning

confidence: 97%

Awareness Of Vocal Hygiene In University-Level Teachers In Delhi-NCR

Mahendru,

Chauha,

Garima

2023

SFS

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 97%

Awareness Of Vocal Hygiene In University-Level Teachers In Delhi-NCR

Mahendru,

Chauha,

Garima

2023

SFS

View full text Add to dashboard Cite

Phonatory function and characteristics of voice in recovering COVID-19 survivors

Yasien

Hassan

Mohamed

2022

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

Introduction This study aimed to evaluate the phonatory function of recovered COVID-19 survivors. The universal outbreak of COVID-19 led to the occurrence of otolaryngological manifestations that raised concerns about the assessment of the phonatory function in recovering patients. Methods This is a prospective, cross-sectional, case-controlled study carried out on 364 laboratory-confirmed non-critical COVID-19 survivors and 100 as healthy controls. The study participants were classified into two groups according to the disease severity. Group1 comprised 212 survivors who recovered from pneumonia and group 2 was made up of 152 survivors of severe pneumonia. All patients were subjected to an auditory perceptual assessment of the voice (APA) and Maximum Phonation Time (MPT) measurements. Results Phonasthenic manifestations were significantly more frequent in COVID-19 survivors than in controls (P < 0.000) with a higher percentage recorded among severe pneumonia survivors (87.5%) than among pneumonia survivors (60.8%) with a P value of < 0.01. Dysphonia and excessively soft loudness were significantly more common among survivors than among controls (P < 0.002 and P < 0.000, respectively) with no significant difference between the patient groups. The MPT was significantly shorter among survivors than among controls (P < 0.000). The mean MPT was 15.97 s in the control group, 10.72 s in the pneumonia group, and 8.88 s in the severe pneumonia group, with the differences between the groups being statistically significant (P < 0.000), suggesting a higher impairment of lung volume and phonatory function in severe cases. Conclusions Phonasthenia, dysphonia, and decreased MPT could be otolaryngological manifestations of COVID-19. Laryngeal function assessment should be considered in COVID-19 survivors.

show abstract

Study of voice disorders in patients with bronchial asthma and chronic obstructive pulmonary disease

et al. 2018

View full text Add to dashboard Cite

Background Chronic obstructive pulmonary disease (COPD) and bronchial asthma are known to cause adverse effects on voice, which might affect the quality of life of an individual. Aim The study was designed to study the voice disorders in patients with COPD and bronchial asthma and its relation to disease severity and medication. Patients and methods Totally, 60 patients were recruited: 30 stable bronchial asthma patients and 30 stable COPD patients. All participants underwent spirometry and study of voice parameters using auditory perceptual assessment, videolaryngostroboscopy system, voice recording, and acoustic analysis. Results Impaired voice quality and various grades of dysphonia were detected in the COPD group in 30% by means of auditory perceptual assessment; structural changes in the vocal folds (diffuse congestion, unhealthy mucosa, and edema) were detected in 36.6%. In the bronchial asthma group, impaired voice quality and various grades of dysphonia were detected in 16.7% and structural changes were detected in 20% of them, whereas acoustic analysis showed a highly significant increase in jitter and shimmer and decreased harmonic-to-noise ratio in 100% of patients of both groups. These changes were greater in metered dose inhaler users than in dry-powder inhaler users. In the bronchial asthma group, fluticasone propionate users had a significantly decreased harmonic-to-noise ratio compared with beclomethasone dipropionate and budesonide users, as well as the least pitch and highest shimmer and jitter. A significant statistical correlation was found between ipratropium inhalation usage and increased shimmer in the COPD group. There was a highly significant correlation between spirometric severity and both grade of dysphonia and character of voice in bronchial asthma patients. Conclusion All COPD and bronchial asthma patients had dysphonia, either due to organic causes or due to functional causes. Voice changes were directly correlated with degree of severity and fluticasone propionate inhalation use in bronchial asthma patients, and with ipratropium bromide inhalation in the COPD group.

show abstract

Association between Lung Function and Vocal Affections Arising from Tobacco Consumption

Cited by 3 publications

References 11 publications

Awareness Of Vocal Hygiene In University-Level Teachers In Delhi-NCR

Awareness Of Vocal Hygiene In University-Level Teachers In Delhi-NCR

Phonatory function and characteristics of voice in recovering COVID-19 survivors

Study of voice disorders in patients with bronchial asthma and chronic obstructive pulmonary disease

Contact Info

Product

Resources

About